XML 19 R8.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Cash flows from operating activities    
Net loss $ (99,352) $ (101,067)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 9,593 12,690
Loss on disposals of assets, net 991 1,286
Impairment of goodwill 9,635 0
Impairment of assets 12,406 0
Gain on sale of discontinued operations 672 0
Loss on release of cumulative foreign currency translation adjustments to loss from discontinued operations 26,957 0
Unrealized and realized (appreciation) depreciation on equity securities and preferred stock, net 106 (5,702)
Amortization of discounts on investments, net (500) (693)
Equity in net loss of affiliates 640 3,387
Stock-based compensation expense 9,269 9,115
Shares issued as payment for services 930 5,688
Provision for credit losses 679 344
Accretion of debt discount and amortization of deferred financing costs 5,101 4,532
Deferred income taxes (136) (981)
Other noncash items (112) 3,141
Receivables:    
Trade (3,679) (3,743)
Related parties (17) (3,317)
Other 1,725 296
Inventory 3,125 3,096
Prepaid expenses and other 3,261 45
Other assets 3 (1,202)
Accounts payable (1,955) (3,686)
Accrued compensation and benefits (1,440) (347)
Other accrued liabilities (3,034) (7,855)
Deferred revenue (15,007) 8,890
Lease liabilities (188) (36)
Related party payables 123 67
Other long-term liabilities 0 (585)
Net cash used in operating activities (41,548) (76,637)
Cash flows from investing activities    
Purchases of investments (133,260) (37,163)
Sales and maturities of investments 57,000 90,000
Proceeds from sales of equity securities 0 589
Investments in affiliates 0 (2,370)
Decrease in cash from deconsolidation of subsidiary   (7,244)
Purchases of property, plant and equipment (5,034) (25,423)
Proceeds from sale of assets 1,526 176
Proceeds from sale of discontinued operations, net of cash sold 64,240  
Proceeds from repayment of notes receivable 2,942 0
Net cash provided by (used in) investing activities (12,586) 18,565
Cash flows from financing activities    
Proceeds from issuance of shares in a private placement 35,000 0
Proceeds from issuance of shares and warrants in public offering, net of issuance costs 0 6,611
Advances from lines of credit 10,005 3,250
Repayments of advances from lines of credit (11,927) (3,329)
Proceeds from long-term debt, net of issuance costs 0 376
Payments of long-term debt (253) (321)
Proceeds from stock option and warrant exercises 66 307
Net cash provided by financing activities 32,891 6,894
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (59) (418)
Net decrease in cash, cash equivalents, and restricted cash (21,302) (51,596)
Cash, cash equivalents, and restricted cash    
Beginning of period 68,434 110,182
End of period 47,132 58,586
Supplemental disclosure of cash flow information    
Cash paid during the period for interest 3,612 3,637
Cash paid during the period for income taxes 40 40
Significant noncash activities    
Accrued compensation paid in equity awards 5,100 1,102
Purchases of property and equipment included in accounts payable and other accrued liabilities 259 1,010
Cash, cash equivalents, and restricted cash    
Cash, cash equivalents, and restricted cash $ 47,132 $ 58,586